Wells Fargo & Company Issues Pessimistic Forecast for Tenet Healthcare (NYSE:THC) Stock Price

Tenet Healthcare (NYSE:THC) had its target price lowered by equities research analysts at Wells Fargo & Company from $265.00 to $213.00 in a research note issued on Friday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of 14.04% from the stock’s previous close.

Other research analysts have also issued reports about the company. Truist Financial raised their price target on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Leerink Partners raised their target price on Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a research note on Friday, February 20th. Guggenheim raised their target price on Tenet Healthcare from $271.00 to $283.00 and gave the company a “buy” rating in a research note on Thursday, March 12th. Wall Street Zen lowered shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 25th. Finally, Mizuho boosted their target price on shares of Tenet Healthcare from $235.00 to $265.00 and gave the stock an “outperform” rating in a report on Thursday, March 12th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $246.28.

Tenet Healthcare Stock Performance

NYSE THC traded up $9.66 during trading hours on Friday, hitting $186.78. The company had a trading volume of 295,616 shares, compared to its average volume of 1,121,441. The firm has a market cap of $16.36 billion, a P/E ratio of 12.01, a price-to-earnings-growth ratio of 1.35 and a beta of 1.49. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. Tenet Healthcare has a fifty-two week low of $145.27 and a fifty-two week high of $247.21. The business has a fifty day simple moving average of $207.31 and a 200-day simple moving average of $204.17.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. The company had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period last year, the company earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities analysts predict that Tenet Healthcare will post 17.31 EPS for the current year.

Insider Buying and Selling

In related news, EVP Paola M. Arbour sold 6,500 shares of Tenet Healthcare stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the transaction, the executive vice president owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the completion of the transaction, the executive vice president directly owned 8,012 shares in the company, valued at $1,875,128.48. This represents a 74.97% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 46,517 shares of company stock valued at $10,943,111. 0.81% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Tenet Healthcare

Institutional investors have recently bought and sold shares of the stock. Triumph Capital Management purchased a new position in Tenet Healthcare during the 3rd quarter valued at about $25,000. Activest Wealth Management acquired a new position in shares of Tenet Healthcare in the 4th quarter valued at about $26,000. Elyxium Wealth LLC acquired a new position in shares of Tenet Healthcare in the 4th quarter valued at about $29,000. William B. Walkup & Associates Inc. acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at about $32,000. Finally, Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at about $35,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare News Roundup

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q1 earnings beat consensus — Tenet reported $4.82 EPS vs. ~$4.21 expected, beating estimates and demonstrating solid profitability and margin control. Zacks: Q1 Earnings Top Estimates
• Positive Sentiment: Big push into ASCs — Tenet deployed ~$125M to acquire seven ASCs in Q1, signaling a strategic shift toward higher-margin outpatient care that should support long-term revenue mix improvement and margin expansion. Becker’s ASC: $125M on 7 ASC acquisitions
• Positive Sentiment: ASC acuity and service expansion — Tenet is seeing double-digit joint replacement growth and runs 150+ robotic surgery programs, which supports higher-acuity outpatient volume and revenue per case over time. Becker’s ASC: ASC acuity push paying off
• Positive Sentiment: Management execution praised — Management attributed navigating Q1 volume variability to disciplined operations, which investors view as supportive of margins and cash flow. FierceHealthcare: Met Q1’s volume curveballs
• Neutral Sentiment: FY?2026 guidance provided — Tenet issued EPS guidance of roughly $16.38–$18.68 (consensus ~17.22) and revenue guidance centered near consensus, leaving room for interpretation but giving investors forward visibility. Yahoo Finance: Q1 2026 Earnings Call Summary
• Negative Sentiment: Revenue slight miss and admissions/payer-mix headwinds — Revenue came in a touch below estimates (~$5.37B vs. $5.39B expected) and management cited an unfavorable admissions mix and external disruptions that weighed on top-line performance. Benzinga: Blames admissions mix for soft Q1 sales

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.